SUBSCRIBE
SUBSCRIBE

Astria Therapeutics

NEWS
Business
BioSpace Movers & Shakers: Astria, Apertura, CytoDyn, IN8bio & More Make Big Moves
New leaders and top executive roles were selected to guide biopharma and life science companies from Apertura Gene Therapy to CytoDyn, Vaccentis AG, Suvoda LLC, IN8bio and more.
July 14, 2022
 · 
9 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Press Releases
BioCryst Receives Early Termination of HSR Waiting Period for Astria Acquisition
December 3, 2025
 · 
7 min read
Press Releases
Astria Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
November 13, 2025
 · 
15 min read
Press Releases
Astria Therapeutics Announces Final Positive Results from All Enrolled HAE Patients in the ALPHA-STAR Phase 1b/2 Trial of Navenibart
November 7, 2025
 · 
9 min read
Press Releases
Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting
October 31, 2025
 · 
1 min read
Press Releases
BioCryst to Acquire Astria Therapeutics, Strengthening Presence in HAE, Transforming Growth Profile
October 15, 2025
 · 
16 min read
Press Releases
Astria Therapeutics to Present at Upcoming CSACI 80th Anniversary Scientific Meeting
October 10, 2025
 · 
1 min read
Press Releases
Astria Therapeutics Initiates the Phase 3 ORBIT-EXPANSE Long-Term Trial of Navenibart in People with Hereditary Angioedema
October 9, 2025
 · 
6 min read
Press Releases
Astria Therapeutics to Present at Upcoming 2025 HAEi Regional Conference EMEA
October 6, 2025
 · 
1 min read
Press Releases
Astria Therapeutics Now Enrolling HAE Patients in the European Union for the Phase 3 ALPHA-ORBIT Trial
October 3, 2025
 · 
8 min read
Press Releases
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 2, 2025
October 3, 2025
 · 
1 min read
Load More